UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

Single vs composite measures of pain intensity: relative sensitivity for detecting treatment effects

Pain (Amsterdam), 2013-04, Vol.154 (4), p.534

2013

Link zum Volltext

Verfügbarkeit prüfen

The relationship between early weight loss and weight loss maintenance with naltrexone-bupropion therapy

EClinicalMedicine, 2022-07, Vol.49, p.101436-101436, Article 101436

2022

Link zum Volltext

Verfügbarkeit prüfen

Measuring Outcomes in Pain Clinical Trials: The Importance of Empirical Support for Measure Selection

The Clinical journal of pain, 2014-09, Vol.30 (9), p.744-748

2014

Link zum Volltext

Verfügbarkeit prüfen

Reliability and Validity of Individual and Composite Recall Pain Measures in Patients with Cancer

Pain medicine (Malden, Mass.), 2012-10, Vol.13 (10), p.1284-1291

2012

Link zum Volltext

Verfügbarkeit prüfen

S119 - Safety and Tolerability of Ascending Doses of ENA-001: A Novel Respiratory Stimulant, for the Intended Management of Pharmacologically-Induced Respiratory Depression

Drug and alcohol dependence, 2024-07, Vol.260

2024

Link zum Volltext

Verfügbarkeit prüfen

The Dimensions of Pain Quality: Factor Analysis of the Pain Quality Assessment Scale

The Clinical journal of pain, 2008-07, Vol.24 (6), p.550-555

2008

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: Post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults

Clinical therapeutics, 2008-12, Vol.30 (12), p.2366-2377

2008

Link zum Volltext

Verfügbarkeit prüfen

The Meaning of Global Outcome Measures in Pain Clinical Trials: More Than Just Change in Pain Intensity

The Clinical journal of pain, 2013-04, Vol.29 (4), p.289-295

2013

Link zum Volltext

Verfügbarkeit prüfen

Oxymorphone extended release for the treatment of chronic low back pain: A retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use

Clinical therapeutics, 2009-02, Vol.31 (2), p.347-359

2009

Link zum Volltext

Verfügbarkeit prüfen

Factors affecting acceptability of titrated oxymorphone extended release in chronic low back pain - an individual patient analysis

Current medical research and opinion, 2010-08, Vol.26 (8), p.1861-1871

2010

Link zum Volltext

Verfügbarkeit prüfen

The Relationship of Changes in Pain Quality to Pain Interference and Sleep Quality

The journal of pain, 2010-08, Vol.11 (8), p.782-788

2010

Link zum Volltext

Verfügbarkeit prüfen

The Pain Quality Response Profile of Oxymorphone Extended Release in the Treatment of Low Back Pain

The Clinical journal of pain, 2009-02, Vol.25 (2), p.116-122

2009

Link zum Volltext

Verfügbarkeit prüfen

Negligible Analgesic Tolerance Seen with Extended Release Oxymorphone: A Post Hoc Analysis of Open-Label Longitudinal Data

Pain medicine (Malden, Mass.), 2010-08, Vol.11 (8), p.1198-1208

2010

Link zum Volltext

Verfügbarkeit prüfen

The Assessment of Pain Quality: An Item Response Theory Analysis

The journal of pain, 2010-03, Vol.11 (3), p.273-279

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetes

Diabetes/metabolism research and reviews, 2002-03, Vol.18 (2), p.127-134

2002

Link zum Volltext

Verfügbarkeit prüfen

Psychiatric Safety and Weight Loss Efficacy of Naltrexone/bupropion as Add-on to Antidepressant Therapy in Patients with Obesity or Overweight

Journal of affective disorders, 2021-06, Vol.289, p.167-176

2021

Link zum Volltext

Verfügbarkeit prüfen

M31 - Novel ‘Agnostic’ Pharmacologic Approach to Polysubstance Overdose

Drug and alcohol dependence, 2024-07, Vol.260

2024

Link zum Volltext

Verfügbarkeit prüfen

Extended‐release naltrexone/bupropion and liver health: Pooled, post hoc analysis from four randomized controlled trials

Diabetes, obesity & metabolism, 2021-03, Vol.23 (3), p.861-865

2021

Link zum Volltext

Verfügbarkeit prüfen

Poster 253: Challenges to Successful Titration of Chronic Low Back Pain Patients to Oxymorphone Extended Release

PM & R, 2009-09, Vol.1 (9), p.S213-S214

2009

Link zum Volltext

Verfügbarkeit prüfen

Poster 251: Opana ER Tolerance in Osteoarthritic Patients: A 1-Year Prospective Study

Archives of physical medicine and rehabilitation, 2008, Vol.89 (11), p.e101-e101

2008

Link zum Volltext

Verfügbarkeit prüfen

Long-term tolerability and effectiveness of oxymorphone extended release in patients with cancer

Journal of opioid management, 2010-05, Vol.6 (3), p.181

2010

Link zum Volltext

Verfügbarkeit prüfen

Relationship between change in pain intensity and functional outcomes in patients with chronic pain receiving twice daily extended-release hydrocodone bitartrate

Journal of opioid management, 2015-09, Vol.11 (5), p.417

2015

Link zum Volltext

Verfügbarkeit prüfen

Poster 199: Age, Sex, and Previous Opioid Use Do Not Affect Clinical Responses to Oxymorphone Extended Release in a Diverse Population of Chronic Low Back Pain Patients

Archives of physical medicine and rehabilitation, 2007, Vol.88 (9), p.E66-E67

2007

Link zum Volltext

Verfügbarkeit prüfen

Poster 339 Dosage Titration of Oxymorphone Extended Release for Relief of Chronic Low Back Pain in Patients With Comorbidities

PM & R, 2011, Vol.3 (10), p.S290-S291

2011

Link zum Volltext

Verfügbarkeit prüfen

Poster 345 Safety and Efficacy of Oxymorphone Extended Release for Chronic Low Back Pain in Patients With Comorbidities

PM & R, 2011, Vol.3 (10), p.S293-S293

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(58)
Dissertationen
(1)

Sprache

Englisch
(59)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Humans
(26)
Male
(22)
Female
(21)
Middle Aged
(20)
Aged
(19)
Adult
(15)
Neurosciences & Neurology
(11)
Treatment Outcome
(11)
Clinical Neurology
(10)
Analgesics, Opioid - Therapeutic Use
(8)
Anesthesiology
(8)
Osteoarthritis
(8)
Pain Measurement - Methods
(8)
Rehabilitation
(8)
Analgesics, Opioid - Administration & Dosage
(7)
Biological And Medical Sciences
(7)
Double-Blind Method
(7)
Neurosciences
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Single vs composite measures of pain intensity: relative sensitivity for detecting treatment effects

The relationship between early weight loss and weight loss maintenance with naltrexone-bupropion therapy

Measuring Outcomes in Pain Clinical Trials: The Importance of Empirical Support for Measure Selection

Reliability and Validity of Individual and Composite Recall Pain Measures in Patients with Cancer

S119 - Safety and Tolerability of Ascending Doses of ENA-001: A Novel Respiratory Stimulant, for the Intended Management of Pharmacologically-Induced Respiratory Depression

The Dimensions of Pain Quality: Factor Analysis of the Pain Quality Assessment Scale

Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: Post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults

The Meaning of Global Outcome Measures in Pain Clinical Trials: More Than Just Change in Pain Intensity

Oxymorphone extended release for the treatment of chronic low back pain: A retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use

Factors affecting acceptability of titrated oxymorphone extended release in chronic low back pain - an individual patient analysis

The Relationship of Changes in Pain Quality to Pain Interference and Sleep Quality

The Pain Quality Response Profile of Oxymorphone Extended Release in the Treatment of Low Back Pain

Negligible Analgesic Tolerance Seen with Extended Release Oxymorphone: A Post Hoc Analysis of Open-Label Longitudinal Data

The Assessment of Pain Quality: An Item Response Theory Analysis

Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetes

Psychiatric Safety and Weight Loss Efficacy of Naltrexone/bupropion as Add-on to Antidepressant Therapy in Patients with Obesity or Overweight

M31 - Novel ‘Agnostic’ Pharmacologic Approach to Polysubstance Overdose

Extended‐release naltrexone/bupropion and liver health: Pooled, post hoc analysis from four randomized controlled trials

Poster 253: Challenges to Successful Titration of Chronic Low Back Pain Patients to Oxymorphone Extended Release

Poster 251: Opana ER Tolerance in Osteoarthritic Patients: A 1-Year Prospective Study

Long-term tolerability and effectiveness of oxymorphone extended release in patients with cancer

Relationship between change in pain intensity and functional outcomes in patients with chronic pain receiving twice daily extended-release hydrocodone bitartrate

Poster 199: Age, Sex, and Previous Opioid Use Do Not Affect Clinical Responses to Oxymorphone Extended Release in a Diverse Population of Chronic Low Back Pain Patients

Poster 339 Dosage Titration of Oxymorphone Extended Release for Relief of Chronic Low Back Pain in Patients With Comorbidities

Poster 345 Safety and Efficacy of Oxymorphone Extended Release for Chronic Low Back Pain in Patients With Comorbidities

Suchergebnisse filtern